| Autor: |
Uskach TM; Chazov National Medical Research Center, Moscow; Russian Medical Academy of Continuous Professional Education, Moscow., Tereschenko SN; Chazov National Medical Research Center, Moscow. |
| Jazyk: |
ruština |
| Zdroj: |
Kardiologiia [Kardiologiia] 2023 Dec 05; Vol. 63 (11), pp. 87-95. Date of Electronic Publication: 2023 Dec 05. |
| DOI: |
10.18087/cardio.2023.11.n2604 |
| Abstrakt: |
Iron deficiency (ID) in patients with heart failure (HF) is a factor for unfavorable course and prognosis of the disease. The significance of ID in the diagnosis and treatment of HF has previously been demonstrated by multiple studies and meta-analyses. Therapy for ID in patients with HF is one of the most relevant and discussed issues. The use of intravenous iron medicinal products for the treatment of ID is currently being actively studied in patients of various categories; attempts are being made to specify the indications for use to produce the greatest effect on the prognosis and quality of life of HF patients. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
